Development and Application of Performance Assessment Criteria for Next-Generation Sequencing-Based HIV Drug Resistance Assays.

Viruses
Michael G BeckerHezhao Ji

Abstract

Next-generation sequencing (NGS)-based HIV drug resistance (HIVDR) assays outperform conventional Sanger sequencing in scalability, sensitivity, and quantitative detection of minority resistance variants. Thus far, HIVDR assays have been applied primarily in research but rarely in clinical settings. One main obstacle is the lack of standardized validation and performance evaluation systems that allow regulatory agencies to benchmark and accredit new assays for clinical use. By revisiting the existing principles for molecular assay validation, here we propose a new validation and performance evaluation system that helps to both qualitatively and quantitatively assess the performance of an NGS-based HIVDR assay. To accomplish this, we constructed a 70-specimen proficiency test panel that includes plasmid mixtures at known ratios, viral RNA from infectious clones, and anonymized clinical specimens. We developed assessment criteria and benchmarks for NGS-based HIVDR assays and used these to assess data from five separate MiSeq runs performed in two experienced HIVDR laboratories. This proposed platform may help to pave the way for the standardization of NGS HIVDR assay validation and performance evaluation strategies for accreditat...Continue Reading

References

Jun 1, 1996·Nature Medicine·M S SaagP A Volberding
Feb 13, 2009·The Journal of Infectious Diseases·Birgitte B SimenUNKNOWN Terry Beirn Community Programs for Clinical Research on AIDS
May 7, 2009·Archives of Pathology & Laboratory Medicine·Lawrence JenningsUNKNOWN College of American Pathologists Molecular Pathology Resource Committee
May 12, 2009·Analytical Sciences : the International Journal of the Japan Society for Analytical Chemistry·Jie FuZhongming Tang
Jan 28, 2010·The Journal of Infectious Diseases·Roger ParedesUNKNOWN AIDS Clinical Trials Group (ACTG) A5095 Study Team
May 15, 2010·The Journal of Antimicrobial Chemotherapy·Jeffrey A Johnson, Anna Maria Geretti
Jul 9, 2010·Clinical Microbiology Reviews·Eileen M Burd
Jun 22, 2012·Journal of Clinical Microbiology·Manuel SchiblerCaroline Tapparel
Nov 10, 2012·Nature Biotechnology·Amy S GargisIra M Lubin
Mar 1, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jonathan Z Li, Daniel R Kuritzkes
Jul 28, 2013·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Heidi L RehmUNKNOWN Working Group of the American College of Medical Genetics and Genomics Laboratory Quality Assurance Commitee
Nov 12, 2013·The Journal of Molecular Diagnostics : JMD·Catherine E CottrellJohn D Pfeifer
Mar 4, 2014·Current Infectious Disease Reports·Richard M GibsonMiguel E Quiñones-Mateu
Apr 16, 2014·Journal of Virological Methods·Birgitte B SimenUNKNOWN 454 HIV Alphastudy Group
Mar 6, 2015·Genetics in Medicine : Official Journal of the American College of Medical Genetics·Sue RichardsUNKNOWN ACMG Laboratory Quality Assurance Committee
Feb 21, 2016·Journal of Clinical Virology : the Official Publication of the Pan American Society for Clinical Virology·Sangeetha Vijaysri NairAndrew Worlock
May 24, 2016·Nature Methods·Benjamin J CallahanSusan P Holmes
Oct 3, 2017·The Journal of Infectious Diseases·Marc Noguera-JulianRoger Paredes
Nov 2, 2017·Nature·Luke R ThompsonUNKNOWN Earth Microbiome Project Consortium
Jul 28, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Huldrych F GünthardDouglas D Richman
Oct 5, 2018·The Lancet. HIV·Seth C InzauleUNKNOWN PanAfrican Studies to Evaluate Resistance
Oct 16, 2018·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Anne DeracheDeenan Pillay
Jan 11, 2019·JAMA : the Journal of the American Medical Association·Robert W EisingerAnthony S Fauci
Mar 19, 2019·Current Opinion in HIV and AIDS·Nicholas BbosaDeogratius Ssemwanga

❮ Previous
Next ❯

Methods Mentioned

BETA
genotyping
PCR
amplicon-seq
protein folding
in vitro transcription

Software Mentioned

ViroDx
HyDRA

Related Concepts

Related Feeds

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.